XML 43 R30.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value of Financial Instruments (Tables)
9 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value
The following table summarizes the valuation of the Company’s remaining assets and liabilities measured at fair value on a recurring basis at March 31, 2023:

TotalQuoted
prices in
active
markets
(Level 1)
Significant
other
observable
inputs
(Level 2)
 (in thousands)
Assets:
Deferred compensation plan investments, current and non-current portion$27,226 $27,226 $ 
Interest rate swap agreement2,654  2,654 
Total assets at fair value$29,880 $27,226 $2,654 
Liabilities:
Deferred compensation plan investments, current and non-current portion$27,226 $27,226 $ 
Forward foreign currency exchange contracts24  24 
Foreign currency hedge230 230 230 
Total liabilities at fair value$27,480 $27,456 $254 

The following table summarizes the valuation of the Company’s remaining assets and liabilities measured at fair value on a recurring basis at June 30, 2022:
TotalQuoted
prices in
active
markets
(Level 1)
Significant
other
observable
inputs
(Level 2)
 (in thousands)
Assets:
Deferred compensation plan investments, current and non-current portion$25,178 $25,178 $— 
Interest rate swap agreement1,686 — 1,686 
Total assets at fair value$26,864 $25,178 $1,686 
Liabilities:
Deferred compensation plan investments, current and non-current portion$25,178 $25,178 $— 
Forward foreign currency exchange contracts— 
Foreign currency hedge93 — 93 
Total liabilities at fair value$25,276 $25,178 $98